The US FTC settles investigation by requiring divestiture of 60 dialysis clinics (Fresenius / Liberty)

Deluard, Ausra

Previous article The UK Competition Appeal Tribunal rejects appeal against merger remedies in the healthcare waste services industry (Stericycle / Ecowaste Southwest) Next article The UK Court of Appeal addresses the issue of the duty of sincere cooperation between national competition authorities and the European institutions in the context of merger control (Ryanair / Aer Lingus)

23 May 2012

The US FTC settles investigation by requiring divestiture of 60 dialysis clinics (Fresenius / Liberty)

KEYWORDS

Reference

US Federal Trade Commission, Fresenius/Liberty, 23 May 2012

To resolve charges that its $2.1 billion acquisition of Liberty Dialysis Holdings, Inc. (Liberty) would harm competition in 43 local markets throughout the United States, Fresenius Medical Care AG & Co. KGaA (Fresenius) agreed to divest 60 outpatient dialysis clinics. U.S.-based Liberty is a provider of outpatient dialysis services in the United States, operating 260 dialysis centers in 32 states and the District of

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

PDF Version

Author

Ausra Deluard
Dentons (San Francisco)

United States 3 contributions 864 visits

Quotation

Ausra Deluard, The US FTC settles investigation by requiring divestiture of 60 dialysis clinics (Fresenius / Liberty), 23 May 2012, e-Competitions May 2012, Art. N° 52959

Visites 324